ClinVar Miner

Submissions for variant NC_000015.10:g.(?_90803511)_(90804369_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001032968 SCV001196275 likely pathogenic Bloom syndrome 2022-09-13 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the helicase and RNase C-terminal (HRDC) domain of the BLM protein, which has been shown to be essential for recruitment of the BLM protein to sites of DNA damage and dissolution of double Holliday junctions (PMID: 22657828, 16876111, 15990871, 22657828). While functional studies have not been performed to directly test the effect of this variant on BLM protein function, this suggests that disruption of this region of the protein is causative of disease. This variant has not been reported in the literature in individuals affected with BLM-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 18-19 of the BLM gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.